KRAS and neoplasm: Previous concordance studies of SOC FFPE KRAS mutation detection assays showed minimal variation in the presence or absence of KRAS mutations, most likely due to differential tumor cell selection from formalin‐fixed tumor tissue (Whitehall et al., 2009).